AG2R LA Mondiale Gestion D Actifs Has $1.65 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

AG2R LA Mondiale Gestion D Actifs grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 16.4% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 22,213 shares of the company’s stock after acquiring an additional 3,128 shares during the quarter. AG2R LA Mondiale Gestion D Actifs’ holdings in GE HealthCare Technologies were worth $1,645,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Hotchkis & Wiley Capital Management LLC grew its holdings in shares of GE HealthCare Technologies by 3.2% during the 1st quarter. Hotchkis & Wiley Capital Management LLC now owns 5,751,773 shares of the company’s stock worth $464,226,000 after purchasing an additional 176,572 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in shares of GE HealthCare Technologies by 49.9% during the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after purchasing an additional 1,711,963 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of GE HealthCare Technologies by 3.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,943,579 shares of the company’s stock worth $398,975,000 after purchasing an additional 157,839 shares in the last quarter. Canada Pension Plan Investment Board grew its holdings in shares of GE HealthCare Technologies by 15.2% during the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock worth $251,121,000 after purchasing an additional 409,636 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of GE HealthCare Technologies by 3.7% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 3,069,114 shares of the company’s stock worth $247,708,000 after purchasing an additional 109,858 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

Shares of GEHC stock opened at $78.14 on Friday. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company has a market cap of $35.68 billion, a P/E ratio of 16.01, a P/E/G ratio of 2.99 and a beta of 1.13. The business has a fifty day simple moving average of $74.78 and a 200 day simple moving average of $72.53.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $0.91 by $0.15. The firm had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period last year, the company earned $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be given a $0.035 dividend. The ex-dividend date is Friday, October 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.87%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on GEHC. Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. BTIG Research upped their price objective on GE HealthCare Technologies from $87.00 to $89.00 and gave the stock a “buy” rating in a research report on Monday, October 13th. Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a research report on Thursday, September 18th. Finally, Barclays began coverage on GE HealthCare Technologies in a research report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price objective for the company. Six investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $85.20.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.